Status:
COMPLETED
Consequences of a Maternal-fetal Chikungunya Virus Infection
Lead Sponsor:
Centre Hospitalier Universitaire de la Réunion
Conditions:
Chikungunya Virus Infection
Eligibility:
All Genders
10-16 years
Phase:
NA
Brief Summary
Chikungunya is an infectious disease caused by an alphavirus transmitted by the Aedes mosquitoes which has known a worldwide expansion since its re-emergence in 2004. Regarding to an unprecedented epi...
Eligibility Criteria
Inclusion
- Child born between March 2005 and July 2006
- Of which the mother identified in the CHIMERE cohort or the perinatal register of maternities
- Exposed: child infected with the chikungunya virus at the time of childbirth
- Not exposed: child not infected with the chikungunya virus at the time of childbirth, verifying the matching criteria specified in chapter 5.2
- Affiliated to a social insurance
Exclusion
- Prematurity \<33 weeks
- Prenatal alcoholization authenticated by fetal alcohol syndrome
- Intellectual disability or secondary epilepsy of origin other than CHIKV infection (caused by ACSOS or any other cause of brain damage of inflammatory, metabolic or infectious origin)
Key Trial Info
Start Date :
January 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 12 2021
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04909411
Start Date
January 13 2020
End Date
October 12 2021
Last Update
January 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de La Réunion
Saint-Pierre, Reunion, 97410